APOLLO MEDICAL HOLDINGS INC (AMEH) Stock Fundamental Analysis
NASDAQ:AMEH - Nasdaq - US03763A2078 - Common Stock - Currency: USD
Taking everything into account, AMEH scores 7 out of 10 in our fundamental rating. AMEH was compared to 102 industry peers in the Health Care Providers & Services industry. AMEH has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. AMEH is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings would make AMEH suitable for growth and quality investing!
1. Profitability
1.1 Basic Checks
In the past year AMEH was profitable.
AMEH had a positive operating cash flow in the past year.
Each year in the past 5 years AMEH has been profitable.
AMEH had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
AMEH's Return On Assets of 4.27% is fine compared to the rest of the industry. AMEH outperforms 74.58% of its industry peers.
AMEH has a Return On Equity of 7.71%. This is in the better half of the industry: AMEH outperforms 71.19% of its industry peers.
With a decent Return On Invested Capital value of 7.06%, AMEH is doing good in the industry, outperforming 75.42% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for AMEH is in line with the industry average of 9.13%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.27% | ||
| ROE | 7.71% | ||
| ROIC | 7.06% |
ROA(3y)6.13%
ROA(5y)4.48%
ROE(3y)12.25%
ROE(5y)10.02%
ROIC(3y)7.61%
ROIC(5y)7.78%
1.3 Margins
AMEH has a Profit Margin of 3.45%. This is in the better half of the industry: AMEH outperforms 75.42% of its industry peers.
In the last couple of years the Profit Margin of AMEH has grown nicely.
The Operating Margin of AMEH (7.61%) is better than 77.97% of its industry peers.
In the last couple of years the Operating Margin of AMEH has grown nicely.
AMEH has a worse Gross Margin (16.34%) than 70.34% of its industry peers.
In the last couple of years the Gross Margin of AMEH has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.61% | ||
| PM (TTM) | 3.45% | ||
| GM | 16.34% |
OM growth 3Y14.1%
OM growth 5YN/A
PM growth 3Y19.41%
PM growth 5YN/A
GM growth 3Y1.75%
GM growth 5Y2.84%
2. Health
2.1 Basic Checks
AMEH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for AMEH has been increased compared to 1 year ago.
AMEH has a better debt/assets ratio than last year.
2.2 Solvency
AMEH has an Altman-Z score of 4.53. This indicates that AMEH is financially healthy and has little risk of bankruptcy at the moment.
AMEH has a Altman-Z score of 4.53. This is amongst the best in the industry. AMEH outperforms 83.90% of its industry peers.
The Debt to FCF ratio of AMEH is 1.89, which is an excellent value as it means it would take AMEH, only 1.89 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.89, AMEH belongs to the top of the industry, outperforming 85.59% of the companies in the same industry.
A Debt/Equity ratio of 0.35 indicates that AMEH is not too dependend on debt financing.
AMEH's Debt to Equity ratio of 0.35 is fine compared to the rest of the industry. AMEH outperforms 65.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.35 | ||
| Debt/FCF | 1.89 | ||
| Altman-Z | 4.53 |
ROIC/WACC0.85
WACC8.27%
2.3 Liquidity
AMEH has a Current Ratio of 2.35. This indicates that AMEH is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.35, AMEH is in the better half of the industry, outperforming 79.66% of the companies in the same industry.
AMEH has a Quick Ratio of 2.35. This indicates that AMEH is financially healthy and has no problem in meeting its short term obligations.
AMEH has a better Quick ratio (2.35) than 81.36% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.35 | ||
| Quick Ratio | 2.35 |
3. Growth
3.1 Past
AMEH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -29.58%.
The Earnings Per Share has been growing by 42.03% on average over the past years. This is a very strong growth
The Revenue has grown by 27.05% in the past year. This is a very strong growth!
Measured over the past years, AMEH shows a very strong growth in Revenue. The Revenue has been growing by 81.94% on average per year.
EPS 1Y (TTM)-29.58%
EPS 3Y42.03%
EPS 5YN/A
EPS Q2Q%-16.07%
Revenue 1Y (TTM)27.05%
Revenue growth 3Y26.85%
Revenue growth 5Y81.94%
Sales Q2Q%9.84%
3.2 Future
The Earnings Per Share is expected to grow by 15.59% on average over the next years. This is quite good.
Based on estimates for the next years, AMEH will show a very strong growth in Revenue. The Revenue will grow by 26.59% on average per year.
EPS Next Y15.47%
EPS Next 2Y16.56%
EPS Next 3Y15.59%
EPS Next 5YN/A
Revenue Next Year25.04%
Revenue Next 2Y26.5%
Revenue Next 3Y26.59%
Revenue Next 5YN/A
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 40.82, the valuation of AMEH can be described as expensive.
Based on the Price/Earnings ratio, AMEH is valued a bit cheaper than 60.17% of the companies in the same industry.
When comparing the Price/Earnings ratio of AMEH to the average of the S&P500 Index (27.75), we can say AMEH is valued slightly more expensively.
Based on the Price/Forward Earnings ratio of 28.34, the valuation of AMEH can be described as expensive.
Based on the Price/Forward Earnings ratio, AMEH is valued a bit cheaper than the industry average as 62.71% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of AMEH to the average of the S&P500 Index (20.49), we can say AMEH is valued slightly more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.82 | ||
| Fwd PE | 28.34 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, AMEH is valued a bit cheaper than 61.86% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, AMEH is valued a bit cheaper than the industry average as 73.73% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.06 | ||
| EV/EBITDA | 15.55 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of AMEH may justify a higher PE ratio.
A more expensive valuation may be justified as AMEH's earnings are expected to grow with 15.59% in the coming years.
PEG (NY)2.64
PEG (5Y)N/A
EPS Next 2Y16.56%
EPS Next 3Y15.59%
5. Dividend
5.1 Amount
No dividends for AMEH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
40.82
-0.88 (-2.11%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners53.14%
Inst Owner Change0.14%
Ins Owners21.32%
Ins Owner Change0%
Market Cap1.90B
Analysts83.33
Price Target47.49 (16.34%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.31
Dividend Growth(5Y)N/A
DP7.9%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.72%
Min EPS beat(2)9.8%
Max EPS beat(2)39.63%
EPS beat(4)3
Avg EPS beat(4)20.8%
Min EPS beat(4)-0.9%
Max EPS beat(4)39.63%
EPS beat(8)6
Avg EPS beat(8)22.78%
EPS beat(12)10
Avg EPS beat(12)32.72%
EPS beat(16)12
Avg EPS beat(16)-118.74%
Revenue beat(2)0
Avg Revenue beat(2)-1.33%
Min Revenue beat(2)-2.49%
Max Revenue beat(2)-0.17%
Revenue beat(4)2
Avg Revenue beat(4)4.65%
Min Revenue beat(4)-2.49%
Max Revenue beat(4)17.32%
Revenue beat(8)6
Avg Revenue beat(8)8.34%
Revenue beat(12)10
Avg Revenue beat(12)8.2%
Revenue beat(16)12
Avg Revenue beat(16)7.16%
PT rev (1m)4.22%
PT rev (3m)-6.25%
EPS NQ rev (1m)-0.44%
EPS NQ rev (3m)7.6%
EPS NY rev (1m)0%
EPS NY rev (3m)-7.34%
Revenue NQ rev (1m)-0.14%
Revenue NQ rev (3m)0.91%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.27%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.82 | ||
| Fwd PE | 28.34 | ||
| P/S | 1.43 | ||
| P/FCF | 17.06 | ||
| P/OCF | 14.21 | ||
| P/B | 3.2 | ||
| P/tB | 7.79 | ||
| EV/EBITDA | 15.55 |
EPS(TTM)1
EY2.45%
EPS(NY)1.44
Fwd EY3.53%
FCF(TTM)2.39
FCFY5.86%
OCF(TTM)2.87
OCFY7.04%
SpS28.49
BVpS12.74
TBVpS5.24
PEG (NY)2.64
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.27% | ||
| ROE | 7.71% | ||
| ROCE | 11.61% | ||
| ROIC | 7.06% | ||
| ROICexc | 10.35% | ||
| ROICexgc | 25.21% | ||
| OM | 7.61% | ||
| PM (TTM) | 3.45% | ||
| GM | 16.34% | ||
| FCFM | 8.4% |
ROA(3y)6.13%
ROA(5y)4.48%
ROE(3y)12.25%
ROE(5y)10.02%
ROIC(3y)7.61%
ROIC(5y)7.78%
ROICexc(3y)12.15%
ROICexc(5y)11.69%
ROICexgc(3y)43.38%
ROICexgc(5y)51.37%
ROCE(3y)12.51%
ROCE(5y)12.79%
ROICexcg growth 3Y1.89%
ROICexcg growth 5YN/A
ROICexc growth 3Y32.67%
ROICexc growth 5YN/A
OM growth 3Y14.1%
OM growth 5YN/A
PM growth 3Y19.41%
PM growth 5YN/A
GM growth 3Y1.75%
GM growth 5Y2.84%
F-Score6
Asset Turnover1.24
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.35 | ||
| Debt/FCF | 1.89 | ||
| Debt/EBITDA | 1.76 | ||
| Cap/Depr | 132.23% | ||
| Cap/Sales | 1.68% | ||
| Interest Coverage | 8.45 | ||
| Cash Conversion | 113.54% | ||
| Profit Quality | 243.47% | ||
| Current Ratio | 2.35 | ||
| Quick Ratio | 2.35 | ||
| Altman-Z | 4.53 |
F-Score6
WACC8.27%
ROIC/WACC0.85
Cap/Depr(3y)82.27%
Cap/Depr(5y)51.68%
Cap/Sales(3y)1.55%
Cap/Sales(5y)1.01%
Profit Quality(3y)102.9%
Profit Quality(5y)124.71%
High Growth Momentum
Growth
EPS 1Y (TTM)-29.58%
EPS 3Y42.03%
EPS 5YN/A
EPS Q2Q%-16.07%
EPS Next Y15.47%
EPS Next 2Y16.56%
EPS Next 3Y15.59%
EPS Next 5YN/A
Revenue 1Y (TTM)27.05%
Revenue growth 3Y26.85%
Revenue growth 5Y81.94%
Sales Q2Q%9.84%
Revenue Next Year25.04%
Revenue Next 2Y26.5%
Revenue Next 3Y26.59%
Revenue Next 5YN/A
EBIT growth 1Y7.56%
EBIT growth 3Y44.74%
EBIT growth 5YN/A
EBIT Next Year55.45%
EBIT Next 3Y28.75%
EBIT Next 5YN/A
FCF growth 1Y77.28%
FCF growth 3Y67.35%
FCF growth 5YN/A
OCF growth 1Y67.48%
OCF growth 3Y81.79%
OCF growth 5YN/A